Lataa...
Targeting the PI3K-AKT-mTOR signaling network in cancer
The phosphoinositide 3-kinase-AKT-mammalian target of rapamycin (PI3K-AKT-mTOR) pathway is a frequently hyperactivated pathway in cancer and is important for tumor cell growth and survival. The development of targeted therapies against mTOR, a vital substrate along this pathway, led to the approval...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Sun Yat-sen University Cancer Center
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3845556/ https://ncbi.nlm.nih.gov/pubmed/23642907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5732/cjc.013.10057 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|